 | • レポートコード：MRC2312MG01132 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、64ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥721,500 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の頭蓋内動脈瘤補助評価ソフトウェア市場規模と予測を収録しています。・世界の頭蓋内動脈瘤補助評価ソフトウェア市場：売上、2018年-2023年、2024年-2029年 ・世界の頭蓋内動脈瘤補助評価ソフトウェア市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の頭蓋内動脈瘤補助評価ソフトウェア市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「身体検査評価型」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 頭蓋内動脈瘤補助評価ソフトウェアのグローバル主要企業は、McKesson、 Elekta、 EndoSoft、 Accuray Incorporated、 Advanced Data Systems、 BioMind、 RaySearch Laboratories、 Varian Medical Systems、 ArteryFlow、 Union Strongなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、頭蓋内動脈瘤補助評価ソフトウェアのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の頭蓋内動脈瘤補助評価ソフトウェア市場：タイプ別、2018年-2023年、2024年-2029年 世界の頭蓋内動脈瘤補助評価ソフトウェア市場：タイプ別市場シェア、2022年 ・身体検査評価型、画像評価型 世界の頭蓋内動脈瘤補助評価ソフトウェア市場：用途別、2018年-2023年、2024年-2029年 世界の頭蓋内動脈瘤補助評価ソフトウェア市場：用途別市場シェア、2022年 ・公立病院、私立病院 世界の頭蓋内動脈瘤補助評価ソフトウェア市場：地域・国別、2018年-2023年、2024年-2029年 世界の頭蓋内動脈瘤補助評価ソフトウェア市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における頭蓋内動脈瘤補助評価ソフトウェアのグローバル売上、2018年-2023年 ・主要企業における頭蓋内動脈瘤補助評価ソフトウェアのグローバル売上シェア、2022年 ・主要企業における頭蓋内動脈瘤補助評価ソフトウェアのグローバル販売量、2018年-2023年 ・主要企業における頭蓋内動脈瘤補助評価ソフトウェアのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 McKesson、 Elekta、 EndoSoft、 Accuray Incorporated、 Advanced Data Systems、 BioMind、 RaySearch Laboratories、 Varian Medical Systems、 ArteryFlow、 Union Strong ************************************************************* ・調査・分析レポートの概要 頭蓋内動脈瘤補助評価ソフトウェア市場の定義 市場セグメント 世界の頭蓋内動脈瘤補助評価ソフトウェア市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の頭蓋内動脈瘤補助評価ソフトウェア市場規模 世界の頭蓋内動脈瘤補助評価ソフトウェア市場規模：2022年 VS 2029年 世界の頭蓋内動脈瘤補助評価ソフトウェア市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの頭蓋内動脈瘤補助評価ソフトウェアの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の頭蓋内動脈瘤補助評価ソフトウェア製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：身体検査評価型、画像評価型 頭蓋内動脈瘤補助評価ソフトウェアのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：公立病院、私立病院 頭蓋内動脈瘤補助評価ソフトウェアの用途別グローバル売上・予測 ・地域別市場分析 地域別頭蓋内動脈瘤補助評価ソフトウェア市場規模 2022年と2029年 地域別頭蓋内動脈瘤補助評価ソフトウェア売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） McKesson、 Elekta、 EndoSoft、 Accuray Incorporated、 Advanced Data Systems、 BioMind、 RaySearch Laboratories、 Varian Medical Systems、 ArteryFlow、 Union Strong ... |
This research report provides a comprehensive analysis of the Intracranial Aneurysm Assistive Evaluation Software market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Intracranial Aneurysm Assistive Evaluation Software market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Intracranial Aneurysm Assistive Evaluation Software, challenges faced by the industry, and potential opportunities for market players.
The global Intracranial Aneurysm Assistive Evaluation Software market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Intracranial Aneurysm Assistive Evaluation Software market presents opportunities for various stakeholders, including Public Hospital, Private Hospital. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Intracranial Aneurysm Assistive Evaluation Software market. Additionally, the growing consumer demand present avenues for market expansion.
The global Intracranial Aneurysm Assistive Evaluation Software market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Intracranial Aneurysm Assistive Evaluation Software market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Intracranial Aneurysm Assistive Evaluation Software market.
Market Overview: The report provides a comprehensive overview of the Intracranial Aneurysm Assistive Evaluation Software market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Physical Examination Assessment Type, Imaging Evaluation Type), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Intracranial Aneurysm Assistive Evaluation Software market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Intracranial Aneurysm Assistive Evaluation Software market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Intracranial Aneurysm Assistive Evaluation Software market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Intracranial Aneurysm Assistive Evaluation Software market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Intracranial Aneurysm Assistive Evaluation Software market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Intracranial Aneurysm Assistive Evaluation Software market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Intracranial Aneurysm Assistive Evaluation Software, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Intracranial Aneurysm Assistive Evaluation Software market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Intracranial Aneurysm Assistive Evaluation Software market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Physical Examination Assessment Type
Imaging Evaluation Type
Market segment by Application
Public Hospital
Private Hospital
Global Intracranial Aneurysm Assistive Evaluation Software Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
McKesson
Elekta
EndoSoft
Accuray Incorporated
Advanced Data Systems
BioMind
RaySearch Laboratories
Varian Medical Systems
ArteryFlow
Union Strong
Outline of Major Chapters:
Chapter 1: Introduces the definition of Intracranial Aneurysm Assistive Evaluation Software, market overview.
Chapter 2: Global Intracranial Aneurysm Assistive Evaluation Software market size in revenue.
Chapter 3: Detailed analysis of Intracranial Aneurysm Assistive Evaluation Software company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Intracranial Aneurysm Assistive Evaluation Software in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Intracranial Aneurysm Assistive Evaluation Software Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Intracranial Aneurysm Assistive Evaluation Software Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Intracranial Aneurysm Assistive Evaluation Software Overall Market Size
2.1 Global Intracranial Aneurysm Assistive Evaluation Software Market Size: 2022 VS 2029
2.2 Global Intracranial Aneurysm Assistive Evaluation Software Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Intracranial Aneurysm Assistive Evaluation Software Players in Global Market
3.2 Top Global Intracranial Aneurysm Assistive Evaluation Software Companies Ranked by Revenue
3.3 Global Intracranial Aneurysm Assistive Evaluation Software Revenue by Companies
3.4 Top 3 and Top 5 Intracranial Aneurysm Assistive Evaluation Software Companies in Global Market, by Revenue in 2022
3.5 Global Companies Intracranial Aneurysm Assistive Evaluation Software Product Type
3.6 Tier 1, Tier 2 and Tier 3 Intracranial Aneurysm Assistive Evaluation Software Players in Global Market
3.6.1 List of Global Tier 1 Intracranial Aneurysm Assistive Evaluation Software Companies
3.6.2 List of Global Tier 2 and Tier 3 Intracranial Aneurysm Assistive Evaluation Software Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Intracranial Aneurysm Assistive Evaluation Software Market Size Markets, 2022 & 2029
4.1.2 Physical Examination Assessment Type
4.1.3 Imaging Evaluation Type
4.2 By Type – Global Intracranial Aneurysm Assistive Evaluation Software Revenue & Forecasts
4.2.1 By Type – Global Intracranial Aneurysm Assistive Evaluation Software Revenue, 2018-2023
4.2.2 By Type – Global Intracranial Aneurysm Assistive Evaluation Software Revenue, 2024-2029
4.2.3 By Type – Global Intracranial Aneurysm Assistive Evaluation Software Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Intracranial Aneurysm Assistive Evaluation Software Market Size, 2022 & 2029
5.1.2 Public Hospital
5.1.3 Private Hospital
5.2 By Application – Global Intracranial Aneurysm Assistive Evaluation Software Revenue & Forecasts
5.2.1 By Application – Global Intracranial Aneurysm Assistive Evaluation Software Revenue, 2018-2023
5.2.2 By Application – Global Intracranial Aneurysm Assistive Evaluation Software Revenue, 2024-2029
5.2.3 By Application – Global Intracranial Aneurysm Assistive Evaluation Software Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Intracranial Aneurysm Assistive Evaluation Software Market Size, 2022 & 2029
6.2 By Region – Global Intracranial Aneurysm Assistive Evaluation Software Revenue & Forecasts
6.2.1 By Region – Global Intracranial Aneurysm Assistive Evaluation Software Revenue, 2018-2023
6.2.2 By Region – Global Intracranial Aneurysm Assistive Evaluation Software Revenue, 2024-2029
6.2.3 By Region – Global Intracranial Aneurysm Assistive Evaluation Software Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Intracranial Aneurysm Assistive Evaluation Software Revenue, 2018-2029
6.3.2 US Intracranial Aneurysm Assistive Evaluation Software Market Size, 2018-2029
6.3.3 Canada Intracranial Aneurysm Assistive Evaluation Software Market Size, 2018-2029
6.3.4 Mexico Intracranial Aneurysm Assistive Evaluation Software Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Intracranial Aneurysm Assistive Evaluation Software Revenue, 2018-2029
6.4.2 Germany Intracranial Aneurysm Assistive Evaluation Software Market Size, 2018-2029
6.4.3 France Intracranial Aneurysm Assistive Evaluation Software Market Size, 2018-2029
6.4.4 U.K. Intracranial Aneurysm Assistive Evaluation Software Market Size, 2018-2029
6.4.5 Italy Intracranial Aneurysm Assistive Evaluation Software Market Size, 2018-2029
6.4.6 Russia Intracranial Aneurysm Assistive Evaluation Software Market Size, 2018-2029
6.4.7 Nordic Countries Intracranial Aneurysm Assistive Evaluation Software Market Size, 2018-2029
6.4.8 Benelux Intracranial Aneurysm Assistive Evaluation Software Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Intracranial Aneurysm Assistive Evaluation Software Revenue, 2018-2029
6.5.2 China Intracranial Aneurysm Assistive Evaluation Software Market Size, 2018-2029
6.5.3 Japan Intracranial Aneurysm Assistive Evaluation Software Market Size, 2018-2029
6.5.4 South Korea Intracranial Aneurysm Assistive Evaluation Software Market Size, 2018-2029
6.5.5 Southeast Asia Intracranial Aneurysm Assistive Evaluation Software Market Size, 2018-2029
6.5.6 India Intracranial Aneurysm Assistive Evaluation Software Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Intracranial Aneurysm Assistive Evaluation Software Revenue, 2018-2029
6.6.2 Brazil Intracranial Aneurysm Assistive Evaluation Software Market Size, 2018-2029
6.6.3 Argentina Intracranial Aneurysm Assistive Evaluation Software Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Intracranial Aneurysm Assistive Evaluation Software Revenue, 2018-2029
6.7.2 Turkey Intracranial Aneurysm Assistive Evaluation Software Market Size, 2018-2029
6.7.3 Israel Intracranial Aneurysm Assistive Evaluation Software Market Size, 2018-2029
6.7.4 Saudi Arabia Intracranial Aneurysm Assistive Evaluation Software Market Size, 2018-2029
6.7.5 UAE Intracranial Aneurysm Assistive Evaluation Software Market Size, 2018-2029
7 Intracranial Aneurysm Assistive Evaluation Software Companies Profiles
7.1 McKesson
7.1.1 McKesson Company Summary
7.1.2 McKesson Business Overview
7.1.3 McKesson Intracranial Aneurysm Assistive Evaluation Software Major Product Offerings
7.1.4 McKesson Intracranial Aneurysm Assistive Evaluation Software Revenue in Global Market (2018-2023)
7.1.5 McKesson Key News & Latest Developments
7.2 Elekta
7.2.1 Elekta Company Summary
7.2.2 Elekta Business Overview
7.2.3 Elekta Intracranial Aneurysm Assistive Evaluation Software Major Product Offerings
7.2.4 Elekta Intracranial Aneurysm Assistive Evaluation Software Revenue in Global Market (2018-2023)
7.2.5 Elekta Key News & Latest Developments
7.3 EndoSoft
7.3.1 EndoSoft Company Summary
7.3.2 EndoSoft Business Overview
7.3.3 EndoSoft Intracranial Aneurysm Assistive Evaluation Software Major Product Offerings
7.3.4 EndoSoft Intracranial Aneurysm Assistive Evaluation Software Revenue in Global Market (2018-2023)
7.3.5 EndoSoft Key News & Latest Developments
7.4 Accuray Incorporated
7.4.1 Accuray Incorporated Company Summary
7.4.2 Accuray Incorporated Business Overview
7.4.3 Accuray Incorporated Intracranial Aneurysm Assistive Evaluation Software Major Product Offerings
7.4.4 Accuray Incorporated Intracranial Aneurysm Assistive Evaluation Software Revenue in Global Market (2018-2023)
7.4.5 Accuray Incorporated Key News & Latest Developments
7.5 Advanced Data Systems
7.5.1 Advanced Data Systems Company Summary
7.5.2 Advanced Data Systems Business Overview
7.5.3 Advanced Data Systems Intracranial Aneurysm Assistive Evaluation Software Major Product Offerings
7.5.4 Advanced Data Systems Intracranial Aneurysm Assistive Evaluation Software Revenue in Global Market (2018-2023)
7.5.5 Advanced Data Systems Key News & Latest Developments
7.6 BioMind
7.6.1 BioMind Company Summary
7.6.2 BioMind Business Overview
7.6.3 BioMind Intracranial Aneurysm Assistive Evaluation Software Major Product Offerings
7.6.4 BioMind Intracranial Aneurysm Assistive Evaluation Software Revenue in Global Market (2018-2023)
7.6.5 BioMind Key News & Latest Developments
7.7 RaySearch Laboratories
7.7.1 RaySearch Laboratories Company Summary
7.7.2 RaySearch Laboratories Business Overview
7.7.3 RaySearch Laboratories Intracranial Aneurysm Assistive Evaluation Software Major Product Offerings
7.7.4 RaySearch Laboratories Intracranial Aneurysm Assistive Evaluation Software Revenue in Global Market (2018-2023)
7.7.5 RaySearch Laboratories Key News & Latest Developments
7.8 Varian Medical Systems
7.8.1 Varian Medical Systems Company Summary
7.8.2 Varian Medical Systems Business Overview
7.8.3 Varian Medical Systems Intracranial Aneurysm Assistive Evaluation Software Major Product Offerings
7.8.4 Varian Medical Systems Intracranial Aneurysm Assistive Evaluation Software Revenue in Global Market (2018-2023)
7.8.5 Varian Medical Systems Key News & Latest Developments
7.9 ArteryFlow
7.9.1 ArteryFlow Company Summary
7.9.2 ArteryFlow Business Overview
7.9.3 ArteryFlow Intracranial Aneurysm Assistive Evaluation Software Major Product Offerings
7.9.4 ArteryFlow Intracranial Aneurysm Assistive Evaluation Software Revenue in Global Market (2018-2023)
7.9.5 ArteryFlow Key News & Latest Developments
7.10 Union Strong
7.10.1 Union Strong Company Summary
7.10.2 Union Strong Business Overview
7.10.3 Union Strong Intracranial Aneurysm Assistive Evaluation Software Major Product Offerings
7.10.4 Union Strong Intracranial Aneurysm Assistive Evaluation Software Revenue in Global Market (2018-2023)
7.10.5 Union Strong Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer